Syndeio Biosciences launches with molecules to target the synapse

Company’s lead candidate is already in a Phase 2 trial for major depressive disorder

May 29, 2025 - 19:45
 0
Syndeio Biosciences launches with molecules to target the synapse
Company’s lead candidate is already in a Phase 2 trial for major depressive disorder